Very-High-Energy Electrons (VHEE)
Intro
Very-High-Energy Electrons (VHEE) are electron beams in the 50–250 MeV range proposed for deep-seated tumour treatment. Above ~100 MeV, electrons penetrate tens of centimetres of tissue with a depth–dose profile that begins to compete with proton beams, while remaining a charged-particle modality that conventional linac technology cannot reach at clinical scale. VHEE is the candidate modality at the intersection of deep penetration, high dose-rate (FLASH), and compact source — provided a high-gradient accelerator can be built.
Concepts
Energy range and depth–dose. Conventional clinical electrons stop at ~6 cm (energies ≤ 20 MeV). At VHEE energies, multiple Coulomb scattering tightens, range straggling becomes manageable, and the dose distribution acquires sharp lateral penumbra. Comparison studies show VHEE plans approach the conformity of intensity-modulated proton therapy for many anatomical sites, though without the proton Bragg peak [[monte-carlo-radiation-transport]].
FLASH coupling. VHEE is one of the few modalities that can simultaneously deliver (a) deep penetration, (b) dose rates ≥ 40 Gy/s associated with the [[flash-therapy]] effect, and (c) sub-second treatment duration. Comparative dosimetry against transmission-proton FLASH treats VHEE as a light-particle alternative: lower mass per projectile, simpler beam optics, no need for a synchrotron.
Source technologies. VHEE accelerators fall into two camps: (i) X-band / C-band radio-frequency structures derived from collider technology, and (ii) [[alp-laser-plasma-accelerator|laser-plasma accelerators]], where the accelerating gradient is three to four orders of magnitude higher than RF. The choice of source dictates beam stability, pulse structure, and machine footprint — central inputs to the radience digital twin.
Open scientific status (2026). No VHEE system is yet approved for clinical use. First-in-human trials with conventional FLASH electron beams (lower energies) have begun [[flash-therapy#fast-01]]; head-to-head VHEE-vs-proton dosimetric studies are accumulating; long-term radiobiology of repeated VHEE fractions remains under investigation.
References
- Vozenin et al., Reviews of Modern Physics
96, 035002 (2024). DOI:10.1103/RevModPhys.96.035002.
Definitive multidisciplinary FLASH review including VHEE positioning. —
vozeninFlash2024 - Böhlen et al., Radiotherapy and Oncology
194, 110177 (2024). DOI:10.1016/j.radonc.2024.110177.
Dosimetric head-to-head VHEE vs transmission-proton FLASH. —
bohlenVHEE2024
Open questions
- What is the minimum electron energy at which VHEE retains dosimetric parity with proton therapy for deep-pelvic tumours? Literature claims diverge between 100 MeV and 250 MeV.
- Are the radiobiological mechanisms underlying the FLASH effect (whatever they are) preserved across the VHEE energy range, or is there an upper-energy regime where the effect attenuates?
- How does the temporal microstructure of a laser-plasma VHEE pulse train interact with the FLASH dose-rate threshold, given that LWFA delivers fs-scale bunches with kHz repetition?
- (empty-marked sub-question) What pencil-beam-scanning equivalent exists for VHEE delivery? — no published proposal as of Tour-0.